CTLA4 and neoplasm: Immunohistochemistrystaining demonstrated that both anti-PD-1 and anti-CTLA-4 therapy increased theinfiltration of CD8+ T cells into the tumour (Fig. 5F, and Supplementary Fig. 8E), however this increase was greaterin anti-PD-1 treated mice.